BACKGROUND: Awake-craniotomy allows maximal tumor resection, which has been associated with extended survival. The feasibility and safety of awake-craniotomy and the effect of extent of resection on survival in the elderly population has not been established. The aim of this study was to compare surgical outcome of elderly patients undergoing awake-craniotomy to that of younger patients. METHODS: Outcomes of consecutive patients younger and older than 65 years who underwent awake-craniotomy at a single institution between 2003 and 2010 were retrospectively reviewed. The groups were compared for clinical variables and surgical outcome parameters, as well as overall survival. RESULTS: A total of 334 young (45.4 ± 13.2 years, mean ± SD) and 90 elderly (71.7 ± 5.1 years) patients were studied. Distribution of gender, mannitol treatment, hemodynamic stability, and extent of tumor resection were similar. Significantly more younger patients had a better preoperative Karnofsky Performance Scale score (>70) than elderly patients (P = 0.0012). Older patients harbored significantly more high-grade gliomas (HGG) and brain metastases, and fewer low-grade gliomas (P < 0.0001). No significantly higher rate of mortality, or complications were observed in the elderly group. Age was associated with increased length of stay (4.9 ± 6.3 vs. 6.6 ± 7.5 days, P = 0.01). Maximal extent of tumor resection in patients with HGG was associated with prolonged survival in the elderly patients. CONCLUSIONS: Awake-craniotomy is a well-tolerated and safe procedure, even in elderly patients. Gross total tumor resection in elderly patients with HGG was associated with prolonged survival. The data suggest that favorable prognostic factors for patients with malignant brain tumors are also valid in elderly patients.
BACKGROUND: Awake-craniotomy allows maximal tumor resection, which has been associated with extended survival. The feasibility and safety of awake-craniotomy and the effect of extent of resection on survival in the elderly population has not been established. The aim of this study was to compare surgical outcome of elderly patients undergoing awake-craniotomy to that of younger patients. METHODS: Outcomes of consecutive patients younger and older than 65 years who underwent awake-craniotomy at a single institution between 2003 and 2010 were retrospectively reviewed. The groups were compared for clinical variables and surgical outcome parameters, as well as overall survival. RESULTS: A total of 334 young (45.4 ± 13.2 years, mean ± SD) and 90 elderly (71.7 ± 5.1 years) patients were studied. Distribution of gender, mannitol treatment, hemodynamic stability, and extent of tumor resection were similar. Significantly more younger patients had a better preoperative Karnofsky Performance Scale score (>70) than elderly patients (P = 0.0012). Older patients harbored significantly more high-grade gliomas (HGG) and brain metastases, and fewer low-grade gliomas (P < 0.0001). No significantly higher rate of mortality, or complications were observed in the elderly group. Age was associated with increased length of stay (4.9 ± 6.3 vs. 6.6 ± 7.5 days, P = 0.01). Maximal extent of tumor resection in patients with HGG was associated with prolonged survival in the elderly patients. CONCLUSIONS: Awake-craniotomy is a well-tolerated and safe procedure, even in elderly patients. Gross total tumor resection in elderly patients with HGG was associated with prolonged survival. The data suggest that favorable prognostic factors for patients with malignant brain tumors are also valid in elderly patients.
Authors: Giannantonio Spena; Philippe Schucht; Kathleen Seidel; Geert-Jan Rutten; Christian Franz Freyschlag; Federico D'Agata; Emanule Costi; Francesca Zappa; Marco Fontanella; Denys Fontaine; Fabien Almairac; Michele Cavallo; Pasquale De Bonis; Gerardo Conesa; Nicholas Foroglou; Santiago Gil-Robles; Emanuel Mandonnet; Juan Martino; Thomas Picht; Catarina Viegas; Michel Wager; Johan Pallud Journal: Neurosurg Rev Date: 2016-08-01 Impact factor: 3.042
Authors: Brett E Youngerman; Alfred I Neugut; Jingyan Yang; Dawn L Hershman; Jason D Wright; Jeffrey N Bruce Journal: J Neurooncol Date: 2017-11-14 Impact factor: 4.130
Authors: Priya Kumthekar; Vaibhav Patel; Carly Bridge; Alfred Rademaker; Irene Helenowski; Maciej M Mrugala; Jason K Rockhill; Sean Grimm; Kristin R Swanson; Jeffrey Raizer Journal: Integr Cancer Sci Ther Date: 2017-10-23
Authors: Kenji Ibayashi; Araceli R Cardenas; Hiroyuki Oya; Hiroto Kawasaki; Christopher K Kovach; Matthew A Howard; Michael A Long; Jeremy D W Greenlee Journal: World Neurosurg Date: 2020-12-08 Impact factor: 2.104
Authors: John J Y Zhang; Keng Siang Lee; Mathew R Voisin; Shawn L Hervey-Jumper; Mitchel S Berger; Gelareh Zadeh Journal: Neurooncol Adv Date: 2020-09-18
Authors: Martin Proescholdt; Stephanie T Jünger; Petra Schödel; Karl-Michael Schebesch; Christian Doenitz; Tobias Pukrop; Julius Höhne; Nils-Ole Schmidt; Martin Kocher; Holger Schulz; Maximilian Ruge; Kevin König; Roland Goldbrunner; Stefan Grau Journal: Brain Sci Date: 2021-01-18